Trial Outcomes & Findings for Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty (NCT NCT00624221)

NCT ID: NCT00624221

Last Updated: 2016-04-27

Results Overview

Endothelial cell density was measured by specular or confocal microscopy. Percent cell loss was calculated by subtracting the graft endothelial cell density measured at 6 months from the baseline donor endothelial cell density and dividing by the baseline donor endothelial cell density then multiplying by 100.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

6 months after grafting

Results posted on

2016-04-27

Participant Flow

Participant milestones

Participant milestones
Measure
Eye Bank Pre-cut Grafts
An Eye bank pre-cut the donor grafts used for the corneal transplant procedures.
Surgeon Dissected Grafts
The surgeon dissected the donor grafts used for the transplant procedures.
Overall Study
STARTED
20
20
Overall Study
COMPLETED
20
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Eye Bank Pre-cut Grafts
n=20 Participants
An Eye bank pre-cut the donor grafts used for the corneal transplant procedures.
Surgeon Dissected Grafts
n=20 Participants
The surgeon dissected the donor grafts used for the transplant procedures.
Total
n=40 Participants
Total of all reporting groups
Age, Continuous
70 years
STANDARD_DEVIATION 12 • n=93 Participants
72 years
STANDARD_DEVIATION 13 • n=4 Participants
71 years
STANDARD_DEVIATION 12 • n=27 Participants
Sex: Female, Male
Female
12 Participants
n=93 Participants
13 Participants
n=4 Participants
25 Participants
n=27 Participants
Sex: Female, Male
Male
8 Participants
n=93 Participants
7 Participants
n=4 Participants
15 Participants
n=27 Participants
Region of Enrollment
United States
20 participants
n=93 Participants
20 participants
n=4 Participants
40 participants
n=27 Participants

PRIMARY outcome

Timeframe: 6 months after grafting

Endothelial cell density was measured by specular or confocal microscopy. Percent cell loss was calculated by subtracting the graft endothelial cell density measured at 6 months from the baseline donor endothelial cell density and dividing by the baseline donor endothelial cell density then multiplying by 100.

Outcome measures

Outcome measures
Measure
Eye Bank Pre-cut Grafts
n=20 Participants
An Eye bank pre-cut the donor grafts used for the corneal transplant procedures.
Surgeon Dissected Grafts
n=20 Participants
The surgeon dissected the donor grafts used for the transplant procedures.
Endothelial Cell Loss
28 percentage of endothelial cell loss
Standard Deviation 20
36 percentage of endothelial cell loss
Standard Deviation 18

SECONDARY outcome

Timeframe: 6 months and 1 year after grafting

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 1 day to 1 month after grafting

Outcome measures

Outcome data not reported

Adverse Events

Eye Bank Pre-cut Grafts

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Surgeon Dissected Grafts

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Eye Bank Pre-cut Grafts
n=20 participants at risk
An Eye bank pre-cut the donor grafts used for the corneal transplant procedures.
Surgeon Dissected Grafts
n=20 participants at risk
The surgeon dissected the donor grafts used for the transplant procedures.
Eye disorders
graft dislocation and reattachment
10.0%
2/20 • Number of events 2 • 1 year
10.0%
2/20 • Number of events 2 • 1 year
Eye disorders
graft rejection episode
10.0%
2/20 • Number of events 2 • 1 year
0.00%
0/20 • 1 year

Additional Information

Marianne O. Price, PhD

Cornea Research Foundation of America

Phone: 317-814-2990

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place